Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep;7(Suppl 4):S484-S489.
doi: 10.21037/tau.2018.03.20.

Percent Gleason pattern 4 in stratifying the prognosis of patients with intermediate-risk prostate cancer

Meenal Sharma  1 , Hiroshi Miyamoto  1   2   3
Affiliations
Review

Percent Gleason pattern 4 in stratifying the prognosis of patients with intermediate-risk prostate cancer

Meenal Sharma et al. Transl Androl Urol. 2018 Sep.

Abstract

The Gleason score remains the most reliable prognosticator in men with prostate cancer. One of the recent important modifications in the Gleason grading system recommended from the International Society of Urological Pathology consensus conference is recording the percentage of Gleason pattern 4 in the pathology reports of prostate needle biopsy and radical prostatectomy cases with Gleason score 7 prostatic adenocarcinoma. Limited data have indeed suggested that the percent Gleason pattern 4 contributes to stratifying the prognosis of patients who undergo radical prostatectomy. An additional obvious benefit of reporting percent pattern 4 includes providing critical information for treatment decisions. This review summarizes and discusses available studies assessing the utility of the percentage of Gleason pattern 4 in the management of prostate cancer patients.

Keywords: Gleason grading; prognosis; prostate biopsy; radical prostatectomy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

References

    1. Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent. Eur Urol 2017;71:618-29. 10.1016/j.eururo.2016.08.003 - DOI - PubMed
    1. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep 1966;50:125-8. - PubMed
    1. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111:58-64. 10.1016/S0022-5347(17)59889-4 - DOI - PubMed
    1. Mellinger GT. Prognosis of prostatic carcinoma. Recent Results Cancer Res 1977;(60):61-72. 10.1007/978-3-642-81095-4_6 - DOI - PubMed
    1. Epstein JI, Allsbrook WC, Jr, Amin MB, et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 2005;29:1228-42. 10.1097/01.pas.0000173646.99337.b1 - DOI - PubMed